Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung. 1994

S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
Department of Medicine III, Osaka University Medical School, Japan.

We constructed a detailed deletion map of the short arm of chromosome 3 (3p) for 55 lung cancer cases by using 17 restriction fragment length polymorphism (RFLP) probes. Initially, we examined 40 small cell lung cancer (SCLC) cases and found three regions of deletion at 3p25-26, 3p21.3 and 3p14-cen, suggesting the possibility of at least three different tumor-suppressor genes on 3p. In order to obtain more detailed deletion area, and to compare the pattern of 3p deletion, we also examined 15 non-small cell lung cancer (NSCLC) cases. Compared to NSCLC cases, most of SCLC cases have widespread deletion on 3p, suggesting multiple tumor-suppressor genes on 3p may be inactivated in this type of cancer. In 3p21.3 area, minimum overlapping area of deletion lays between two probes which are close to each other. These data will be useful to isolate the putative tumor-suppressor genes located on the chromosome 3p.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002893 Chromosomes, Human, Pair 3 A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. Chromosome 3
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D018288 Carcinoma, Small Cell An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7) Carcinoma, Oat Cell,Oat Cell Carcinoma,Small Cell Carcinoma,Carcinomas, Oat Cell,Carcinomas, Small Cell,Oat Cell Carcinomas,Small Cell Carcinomas

Related Publications

S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
June 1993, Genes, chromosomes & cancer,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
September 1991, Cancer research,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
June 1994, International journal of oncology,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
February 1996, Genes, chromosomes & cancer,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
February 1992, Cancer research,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
February 1993, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
June 1999, International journal of cancer,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
October 1987, The New England journal of medicine,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
January 2000, Cancer detection and prevention,
S Hosoe, and Y Shigedo, and K Ueno, and I Tachibana, and T Osaki, and Y Tanio, and I Kawase, and K Yamakawa, and Y Nakamura, and T Kishimoto
December 1994, Cancer research,
Copied contents to your clipboard!